FSA
Franklin Street Advisors Portfolio holdings
AUM
$1.61B
1-Year Return
24.37%
This Quarter Return
+16.47%
1 Year Return
+24.37%
3 Year Return
+112.05%
5 Year Return
+186.1%
10 Year Return
+475.68%
AUM
$1.61B
AUM Growth
+$198M
(+14%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
42.35%
Holding
181
New
14
Increased
57
Reduced
47
Closed
8
Top Buys
| 1 |
Eaton
ETN
|
$9.49M |
| 2 |
Martin Marietta Materials
MLM
|
$8.77M |
| 3 |
Goldman Sachs
GS
|
$7.47M |
| 4 |
Evergy
EVRG
|
$6.04M |
| 5 |
Bristol-Myers Squibb
BMY
|
$5.42M |
Top Sells
| 1 |
Dell
DELL
|
$11.9M |
| 2 |
Parker-Hannifin
PH
|
$10.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
$6.68M |
| 4 |
Amgen
AMGN
|
$5.87M |
| 5 |
Aflac
AFL
|
$4.17M |
Sector Composition
| 1 | Technology | 33.27% |
| 2 | Financials | 17.37% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Communication Services | 10.07% |
| 5 | Healthcare | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Pfizer
PFE
$140B
| $1.33M | 0.08% |
54,831
+11,668
| +27% | +$283K |
|
|
ETW
77
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$975M
| $1.3M | 0.08% |
150,334
| – | – |
|
78
Waste Management
WM
$90.5B
| $1.29M | 0.08% |
5,642
+1,235
| +28% | +$283K |
|
79
Philip Morris
PM
$249B
| $1.28M | 0.08% |
7,034
-1,180
| -14% | -$215K |
|
80
Charles Schwab
SCHW
$177B
| $1.19M | 0.07% |
13,059
| – | – |
|
81
Altria Group
MO
$112B
| $1.15M | 0.07% |
19,579
+910
| +5% | +$53.4K |
|
82
Stryker
SYK
$151B
| $948K | 0.06% |
2,395
+15
| +0.6% | +$5.94K |
|
|
83
Amgen
AMGN
$151B
| $943K | 0.06% |
3,378
-21,044
| -86% | -$5.87M |
|
84
Blackstone
BX
$133B
| $915K | 0.06% |
6,116
-3,812
| -38% | -$570K |
|
85
Vanguard Industrials ETF
VIS
$6.11B
| $884K | 0.05% |
3,157
| – | – |
|
86
AT&T
T
$211B
| $868K | 0.05% |
30,000
+4,203
| +16% | +$122K |
|
87
DraftKings
DKNG
$23.5B
| $858K | 0.05% |
20,000
| – | – |
|
88
NextEra Energy, Inc.
NEE
$146B
| $845K | 0.05% |
12,176
| – | – |
|
89
Ecolab
ECL
$77.8B
| $837K | 0.05% |
3,108
-141
| -4% | -$38K |
|
90
Gilead Sciences
GILD
$140B
| $837K | 0.05% |
7,552
| – | – |
|
91
PepsiCo
PEP
$202B
| $722K | 0.04% |
5,471
+161
| +3% | +$21.2K |
|
92
Netflix
NFLX
$533B
| $698K | 0.04% |
+521
| New | +$698K |
|
93
Travelers Companies
TRV
$62.9B
| $690K | 0.04% |
2,579
| – | – |
|
94
DexCom
DXCM
$31.7B
| $686K | 0.04% |
+7,860
| New | +$686K |
|
|
SBR
95
Sabine Royalty Trust
SBR
$1.11B
| $672K | 0.04% |
10,081
| – | – |
|
96
Huntsman Corp
HUN
$1.91B
| $651K | 0.04% |
62,500
| – | – |
|
97
Southern Company
SO
$101B
| $646K | 0.04% |
7,038
-405
| -5% | -$37.2K |
|
98
Mondelez International
MDLZ
$79.1B
| $635K | 0.04% |
9,420
-523
| -5% | -$35.3K |
|
99
Supernus Pharmaceuticals
SUPN
$2.54B
| $630K | 0.04% |
20,000
| – | – |
|
100
Protagonist Therapeutics
PTGX
$3.66B
| $625K | 0.04% |
11,300
| – | – |
|